% alzhub.org library filter
% Source: https://alzhub.org/research?author=Sabbagh+M
% 17 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{sabbagh2020-31879235,
  author  = {Sabbagh, M. and Sadowsky, C. and Tousi, B. and Agronin, M. E. and Alva, G. and Armon, C. and Bernick, C. and Keegan, A. P. and others},
  title   = {{Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1016/j.jalz.2019.08.197},
  pmid    = {31879235},
  url     = {https://doi.org/10.1016/j.jalz.2019.08.197}
}

@article{vandyck2023-22dd8fce,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and Reyderman, L. and Cohen, S. and Froelich, L. and Katayama, S. and Sabbagh, M. and Vellas, B. and Watson, D. and Dhadda, S. and Irizarry, M. and Kramer, L. D. and Iwatsubo, T.},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2023},
  pmid    = {36449413}
}

@article{salloway2009-19923550,
  author  = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181c67808},
  pmid    = {19923550},
  url     = {https://doi.org/10.1212/wnl.0b013e3181c67808}
}

@article{study2007-17460158,
  author  = {{ADAPT Research Group} and Lyketsos, C. G. and Breitner, J. C. and Green, R. C. and Martin, B. K. and Meinert, C. and Piantadosi, S. and Sabbagh, M.},
  title   = {{Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial}},
  journal = {Neurology},
  year    = {2007},
  doi     = {10.1212/01.wnl.0000260269.93245.d2},
  pmid    = {17460158},
  url     = {https://doi.org/10.1212/01.wnl.0000260269.93245.d2}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{bahureksa2017-27172932,
  author  = {Bahureksa, L. and Najafi, B. and Saleh, A. and Sabbagh, M. and Coon, D. and Mohler, M. J. and Schwenk, M.},
  title   = {{The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented Assessment}},
  journal = {Gerontology},
  year    = {2017},
  doi     = {10.1159/000445831},
  pmid    = {27172932},
  url     = {https://doi.org/10.1159/000445831}
}

@article{sperling2012-22305802,
  author  = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others},
  title   = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70015-7},
  pmid    = {22305802},
  url     = {https://doi.org/10.1016/s1474-4422(12)70015-7}
}

@article{cummings2020-32695874,
  author  = {Cummings, J. and Lee, G. and Ritter, A. and Sabbagh, M. and Zhong, K.},
  title   = {{Alzheimer's disease drug development pipeline: 2020}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2020},
  doi     = {10.1002/trc2.12050},
  pmid    = {32695874},
  url     = {https://doi.org/10.1002/trc2.12050}
}

@article{baumel2021-33368017,
  author  = {Baumel, B. S. and Doraiswamy, P. M. and Sabbagh, M. and Wurtman, R.},
  title   = {{Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review}},
  journal = {Neurology and therapy},
  year    = {2021},
  doi     = {10.1007/s40120-020-00227-y},
  pmid    = {33368017},
  url     = {https://doi.org/10.1007/s40120-020-00227-y}
}

@article{mehta2017-28460541,
  author  = {Mehta, D. and Jackson, R. and Paul, G. and Shi, J. and Sabbagh, M.},
  title   = {{Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015}},
  journal = {Expert opinion on investigational drugs},
  year    = {2017},
  doi     = {10.1080/13543784.2017.1323868},
  pmid    = {28460541},
  url     = {https://doi.org/10.1080/13543784.2017.1323868}
}

@article{rogers2023-36935024,
  author  = {Rogers, C. L. and Lageman, S. K. and Fontanesi, J. and Wilson, G. D. and Boling, P. A. and Bansal, S. and Karis, J. P. and Sabbagh, M. and others},
  title   = {{Low-Dose Whole Brain Radiation Therapy for Alzheimer's Dementia: Results From a Pilot Trial in Humans}},
  journal = {International journal of radiation oncology, biology, physics},
  year    = {2023},
  doi     = {10.1016/j.ijrobp.2023.03.044},
  pmid    = {36935024},
  url     = {https://doi.org/10.1016/j.ijrobp.2023.03.044}
}

@article{cummings2019-31334330,
  author  = {Cummings, J. and Lee, G. and Ritter, A. and Sabbagh, M. and Zhong, K.},
  title   = {{Alzheimer's disease drug development pipeline: 2019}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.05.008},
  pmid    = {31334330},
  url     = {https://doi.org/10.1016/j.trci.2019.05.008}
}

@article{cummings2022-35542993,
  author  = {Cummings, J. and Rabinovici, G. D. and Atri, A. and Aisen, P. and Apostolova, L. G. and Hendrix, S. and Sabbagh, M. and Selkoe, D. and others},
  title   = {{Aducanumab: Appropriate Use Recommendations Update}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.34},
  pmid    = {35542993},
  url     = {https://doi.org/10.14283/jpad.2022.34}
}

@article{tolar2020-32787971,
  author  = {Tolar, M. and Abushakra, S. and Hey, J. A. and Porsteinsson, A. and Sabbagh, M.},
  title   = {{Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval}},
  journal = {Alzheimer's research \& therapy},
  year    = {2020},
  doi     = {10.1186/s13195-020-00663-w},
  pmid    = {32787971},
  url     = {https://doi.org/10.1186/s13195-020-00663-w}
}

@article{tolar2020-31706733,
  author  = {Tolar, M. and Abushakra, S. and Sabbagh, M.},
  title   = {{The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1016/j.jalz.2019.09.075},
  pmid    = {31706733},
  url     = {https://doi.org/10.1016/j.jalz.2019.09.075}
}

@article{mehta2012-22216416,
  author  = {Mehta, M. and Adem, A. and Sabbagh, M.},
  title   = {{New acetylcholinesterase inhibitors for Alzheimer's disease}},
  journal = {International journal of Alzheimer's disease},
  year    = {2012},
  doi     = {10.1155/2012/728983},
  pmid    = {22216416},
  url     = {https://doi.org/10.1155/2012/728983}
}